HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manish Kohli Selected Research

Prostate-Specific Antigen (Semenogelase)

2/2021Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer.
1/2018Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel.
5/2014Preclinical evaluation of the supercritical extract of azadirachta indica (neem) leaves in vitro and in vivo on inhibition of prostate cancer tumor growth.
6/2012The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: results from a population-based cohort.
6/2006Evaluation of an adrenal mass in a patient with progressive prostate cancer reveals pheochromocytoma.
4/2006Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.
9/2005Orbital metastasis from prostate cancer: an atypical case of neuroendocrine dedifferentiation during progression from hormone-sensitive to refractory stage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manish Kohli Research Topics

Disease

84Prostatic Neoplasms (Prostate Cancer)
04/2024 - 06/2003
50Neoplasms (Cancer)
04/2024 - 01/2003
12Neoplasm Metastasis (Metastasis)
03/2024 - 01/2003
12Renal Cell Carcinoma (Grawitz Tumor)
10/2023 - 07/2006
7Disease Progression
10/2023 - 03/2014
6Carcinoma (Carcinomatosis)
10/2017 - 12/2004
5Circulating Neoplastic Cells
01/2023 - 08/2017
4Hypertension (High Blood Pressure)
01/2019 - 03/2014
3Fatigue
04/2024 - 03/2014
3Cardiotoxicity
01/2019 - 09/2014
2Adenocarcinoma
12/2023 - 01/2018
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2019
1Residual Neoplasm
08/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Carcinogenesis
01/2018

Drug/Important Bio-Agent (IBA)

30AndrogensIBA
04/2024 - 10/2004
23Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2006
17Hormones (Hormone)IBA
03/2024 - 10/2004
15Androgen Receptors (Androgen Receptor)IBA
12/2023 - 01/2010
13Docetaxel (Taxotere)FDA Link
01/2022 - 10/2004
11MicroRNAs (MicroRNA)IBA
11/2023 - 05/2013
11Cell-Free Nucleic AcidsIBA
10/2023 - 01/2015
10RNA (Ribonucleic Acid)IBA
12/2023 - 02/2006
10Abiraterone AcetateIBA
11/2023 - 01/2012
10DNA (Deoxyribonucleic Acid)IBA
10/2023 - 01/2010
8Prednisone (Sone)FDA LinkGeneric
11/2023 - 10/2004
8Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2005
8Messenger RNA (mRNA)IBA
01/2020 - 01/2005
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2005
7enzalutamideIBA
10/2023 - 01/2012
7abirateroneIBA
10/2023 - 08/2017
7Prostate-Specific Antigen (Semenogelase)IBA
02/2021 - 09/2005
5Sunitinib (Sutent)FDA Link
10/2023 - 03/2014
4Transcription Factors (Transcription Factor)IBA
12/2023 - 08/2017
4Circulating Tumor DNAIBA
01/2021 - 04/2020
3Phenobarbital (Luminal)FDA Link
12/2023 - 01/2018
3LipidsIBA
01/2023 - 03/2012
3Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2013
3ProteomeIBA
08/2020 - 01/2006
2taxaneIBA
12/2023 - 05/2021
2Chromogranin AIBA
01/2023 - 01/2018
2big gastrinIBA
01/2021 - 01/2020
2Nucleic AcidsIBA
08/2020 - 03/2019
2Androgen Antagonists (Antiandrogens)IBA
01/2018 - 01/2018
2ChromatinIBA
01/2018 - 01/2018
2PlatinumIBA
08/2017 - 01/2016
2Dihydrotestosterone (Androstanolone)IBA
10/2016 - 05/2014
2Enhancer RNAsIBA
06/2016 - 04/2016
2Sorafenib (BAY 43-9006)FDA Link
05/2016 - 04/2011
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2016 - 01/2005
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2016 - 01/2005
2Thromboplastin (Tissue Factor)IBA
05/2009 - 01/2008
2Mitoxantrone (Novantrone)FDA LinkGeneric
04/2006 - 10/2004
2EstramustineFDA Link
04/2006 - 10/2004
1Complement System Proteins (Complement)IBA
04/2024
1CreatineIBA
04/2024
1Ribose (D-Ribose)IBA
03/2024
1Diphosphates (Pyrophosphates)IBA
03/2024
1Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2024
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
03/2024
1polyadenosineIBA
03/2024
1rucaparibIBA
03/2024
1Histones (Histone)IBA
12/2023
15-hydroxymethylcytosineIBA
10/2023
1GemcitabineFDA Link
10/2023
1Epithelial Cell Adhesion MoleculeIBA
01/2023
1Surface Antigens (Surface Antigen)IBA
01/2023
1orteronelIBA
10/2022
1bicalutamide (Casodex)FDA LinkGeneric
10/2022
1Aligeron (AS 2)IBA
01/2022
1SphingolipidsIBA
01/2022
1Radium-223IBA
12/2021
1Factor V (Coagulation Factor V)IBA
11/2021
1Neuropilin-2IBA
05/2021
1Peptides (Polypeptides)IBA
01/2021
1relugolixIBA
01/2021
1CeramidesIBA
01/2021
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1apalutamideIBA
01/2021
1Tumor Biomarkers (Tumor Markers)IBA
08/2020
1Retinoblastoma ProteinIBA
01/2019
1Collagenases (Collagenase)FDA Link
01/2018
1Testosterone (Sustanon)FDA Link
01/2018
1palbociclibIBA
01/2018
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2018
1Cytochrome P-450 CYP3AIBA
01/2018
1Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA
01/2018
1Cyclin-Dependent Kinase 4IBA
01/2018

Therapy/Procedure

46Therapeutics
04/2024 - 12/2004
36Castration
04/2024 - 01/2010
16Drug Therapy (Chemotherapy)
01/2022 - 10/2004
3Combined Modality Therapy
01/2021 - 08/2014
3Prostatectomy (Retropubic Prostatectomy)
10/2016 - 01/2006
2Immunotherapy
01/2023 - 10/2017
2Aftercare (After-Treatment)
08/2020 - 06/2012
2Radiotherapy
12/2010 - 01/2006
1Resistance Training
04/2024
1Ligation
06/2022
1Combination Drug Therapy (Combination Chemotherapy)
01/2021